Time to reconsider what Global Burden of Disease studies really tell us about low back pain

Chris Maher,Giovanni Ferreira

DOI: https://doi.org/10.1136/annrheumdis-2021-221173

IF: 27.973

2021-09-28

Annals of the Rheumatic Diseases

Abstract:Introduction Most of us have read publications where the introduction includes a statistic from one of the Global Burden of Disease (GBD) studies.1 2 We may be told that musculoskeletal conditions are very common,3 low back pain (LBP) is the leading cause of disability worldwide,4 neck pain is most prevalent in Scandinavia3 and the burden of osteoarthritis is increasing,5 but have you ever stopped to think about the data underpinning these claims? In this perspective, we considered three limitations of the GBD Study that need to be borne in mind when considering GBD Study results. We used LBP as an exemplar, but the limitations apply more generally. But first we begin with an introduction to the metrics used in the GBD Study. GBD 101 There are four GBD Study metrics commonly used to provide information...

rheumatology